A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
Clinical trial NCT01100944 · TERMINATED
Trial details
- NCT number
- NCT01100944
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-04
- Primary completion
- 2015-10-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.